Koyfin Home > Directory > Health Care > Kindred Biosciences > Issuance of Common Stock

Kindred Biosciences Issuance of Common Stock Chart (KIN)

Kindred Biosciences annual/quarterly Issuance of Common Stock from 2013 to 2020.
  • Kindred Biosciences Issuance of Common Stock for the quarter ending June 06, 2020 was $0m a -34.31% decrease of 0m year over year
  • Kindred Biosciences Issuance of Common Stock for the last 12 months ending June 06, 2020 was $4m a -1,099.16% decrease of -44m year over year
  • Kindred Biosciences Annual Issuance of Common Stock for 2019 was $48m a -11.26% decrease of -5m from 2018
  • Kindred Biosciences Annual Issuance of Common Stock for 2018 was $53m a -1.57% decrease of -1m from 2017
  • Kindred Biosciences Annual Issuance of Common Stock for 2017 was $54m a 99.70% increase of 54m from 2016
Other Cash Flow Metrics:
  • Kindred Biosciences Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a 12.86% decrease of -2m year over year
  • Kindred Biosciences Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-16m a 50.99% decrease of -8m year over year
  • Kindred Biosciences Total Revenue for the quarter ending September 09, 2018 was $1m
View Chart On Koyfin

Quarterly KIN Issuance of Common Stock Data

06/2020$0m
03/2020$0m
12/2019$4m
09/2019$0m
06/2019$1m
03/2019$44m
12/2018$4m
09/2018$0m
06/2018$49m
03/2018$0m

Annual KIN Issuance of Common Stock Data

2019$48m
2018$53m
2017$54m
2016$0m
2015$0m
2014$58m
2013$55m